The digital health market is constantly changing, with startups coming onto the scene and more established companies restructuring their strategies. Here’s how four companies performed over the last week.
A new report from Panda Health predicts that digital health tools used by hospitals to cope with the COVID-19 pandemic will be subject to increased scrutiny and turnover.
DNA testing company 23andMe said it plans to lay off about 75 employees, or 9 percent of its staff, in a cost-cutting move, according to a securities filing.